Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biliary System Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02375880
What this trial is testing

Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder

Who this might be right for
Carcinoma of Intrahepatic and Extra-hepatic Biliary SystemCarcinoma of GallbladderBile Duct Cancer+1 more
Leap Therapeutics, Inc. 51
Not applicableStudy completedNCT06960486
What this trial is testing

Ultrasound-guided Biliary Drainage Improving Prognosis in the Frail and High Risk Elderly Patients

Who this might be right for
Biliary Tract Infection
Hebei Medical University 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06569225
What this trial is testing

Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig in Resectable iCCA

Who this might be right for
Cholangiocarcinoma Resectable
University Health Network, Toronto 40
Testing effectiveness (Phase 2)Looking for participantsNCT05503797
What this trial is testing

Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Who this might be right for
Cancer Harboring BRAF AlterationsHGGLGG+1 more
Fore Biotherapeutics 254
Testing effectiveness (Phase 2)Looking for participantsNCT06431490
What this trial is testing

TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 102
Not applicableStudy completedNCT03327688
What this trial is testing

Point-of-care Ultrasound in Finland

Who this might be right for
Deep Vein ThrombosisAbdominal Aortic AneurismPneumothorax+6 more
Ossi Hannula 220
Not applicableStudy completedNCT01190280
What this trial is testing

Indications for Gallbladder Surgery in Gallstone Disease

Who this might be right for
Gallstones
Haraldsplass Deaconess Hospital 500
Early research (Phase 1)Active Not RecruitingNCT02495896
What this trial is testing

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Pancreatic AdenocarcinomaNon-Resectable Cholangiocarcinoma+13 more
University of Southern California 61
Large-scale testing (Phase 3)WithdrawnNCT04531878
What this trial is testing

BSEP Function Rescue During Childhood Inhereditary Cholestatic Diseases

Who this might be right for
Hereditary DiseasesCholestasis, Intrahepatic
Children's Hospital of Fudan University
Testing effectiveness (Phase 2)Study completedNCT03230318
What this trial is testing

Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaCombined Hepatocellular and Cholangiocarcinoma
Basilea Pharmaceutica 148
Not applicableStudy completedNCT02357589
What this trial is testing

3D vs 2D HD Laparoscopy in Cholecystectomy

Who this might be right for
Cholecystolithiasis
Helsinki University Central Hospital 210
Testing effectiveness (Phase 2)Study completedNCT00268840
What this trial is testing

The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer

Who this might be right for
Pancreatic NeoplasmsBiliary Tract Neoplasms
ARCAGY/ GINECO GROUP 45
Not applicableStudy completedNCT07772440
What this trial is testing

Multicenter Cohort of 768 High-risk Patients With Symptomatic Gallstones, Adding Cholecystectomy Did Not Increase Length of Stay or Perioperative Morbidity, Supporting it as a Safe Single-stage Option

Who this might be right for
Bariatric Surgery CandidateCholelithiases
Zagazig University 2,512
Testing effectiveness (Phase 2)Ended earlyNCT04566133
What this trial is testing

Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).

Who this might be right for
Bile Duct CancerBiliary CancerBiliary Tract Neoplasms+1 more
National Cancer Institute (NCI) 2
Not applicableStudy completedNCT04052633
What this trial is testing

Success of Intraoperative Cholangiography

Who this might be right for
CholecystolithiasisCholedocholithiasis
Jyväskylä Central Hospital 201
Large-scale testing (Phase 3)Looking for participantsNCT05786716
What this trial is testing

DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations

Who this might be right for
Haematological MalignancyColorectal NeoplasmsUrinary Bladder Neoplasm+8 more
Cancer Research UK 30
Not applicableStudy completedNCT02630433
What this trial is testing

Trial of Index Cholecystectomy Versus Scheduled Cholecystectomy in Biliary Pancreatitis

Who this might be right for
Pancreatitis
Karolinska Institutet 65
Not applicableStudy completedNCT02956252
What this trial is testing

Spinal Versus General Anesthesia for Laparoscopic Cholecystectomy

Who this might be right for
CholecystitisGallbladder Diseases
Medical Park Gaziantep Hospital 1,500
Testing effectiveness (Phase 2)Looking for participantsNCT07267078
What this trial is testing

Tuvonralimab and Iparomlimab Based Regimens for the Neoadjuvant Treatment of Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Peking Union Medical College Hospital 45
Large-scale testing (Phase 3)Study completedNCT03662282
What this trial is testing

Omegaven as Alternative Parenteral Fat Nutrition

Who this might be right for
CholestasisCholestasis of Parenteral Nutrition
University of South Florida 2
Next Page